phosphatidylcholines has been researched along with Diabetic Angiopathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, S; Barter, PJ; Bonnet, DJ; Brown, BE; Curtiss, LK; Davies, MJ; Dusting, GJ; Jenkins, AJ; Lambert, G; Nobécourt, E; Puranik, R; Rye, KA; Tabet, F; Yan, L | 1 |
| Belcaro, G; Cesarone, MR; Cornelli, U; Dugall, M; Feragalli, B; Hosoi, M; Luzzi, R | 1 |
| Cassagne, C; Diakou, V; Gin, H; Maneta-Peyret, L; Perret, AM; Poix, J; Vergnot, V | 1 |
| Gabbe, SG; Goetz, FC; Hare, JW; Kitzmiller, JL; Miodovnik, M; Nagel, TC; Ogburn, PL; Phillippe, M; Tagatz, GE; Williams, PP | 1 |
| Voskresenskiĭ, ON | 1 |
| Haugen, HN; Walaas, E; Wille, L | 1 |
1 review(s) available for phosphatidylcholines and Diabetic Angiopathies
| Article | Year |
|---|---|
[Pancreatic hormones and arteriosclerosis].
Topics: Aging; Animals; Arteriosclerosis; Blood Proteins; Cholesterol; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dogs; Fatty Acids; Fatty Liver; Glucagon; Guinea Pigs; Hypercholesterolemia; Insulin; Insulin Secretion; Lipotropic Agents; NADP; Obesity; Pancreatectomy; Phosphatidylcholines; Rabbits; Rats; Sterols; Tissue Extracts | 1967 |
1 trial(s) available for phosphatidylcholines and Diabetic Angiopathies
| Article | Year |
|---|---|
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy.
Topics: Administration, Topical; Adult; Cardiovascular Agents; Diabetic Angiopathies; Escin; Female; Gels; Heparin; Humans; Male; Microcirculation; Middle Aged; Phosphatidylcholines; Registries; Treatment Outcome; Venous Insufficiency | 2011 |
4 other study(ies) available for phosphatidylcholines and Diabetic Angiopathies
| Article | Year |
|---|---|
Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.
Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents; Apolipoprotein A-I; Carotid Arteries; Carotid Artery Injuries; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Glycosylation; Humans; I-kappa B Proteins; Inflammation; Infusions, Parenteral; Intercellular Adhesion Molecule-1; Lipoproteins, HDL; Neutrophil Infiltration; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphatidylcholines; Phosphorylation; Protein Processing, Post-Translational; Pyruvaldehyde; Rabbits; Reactive Oxygen Species; Time Factors; Vascular Cell Adhesion Molecule-1 | 2010 |
Anti-phospholipid antibodies in diabetes mellitus.
Topics: Adult; Antibodies, Antiphospholipid; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Phosphatidylcholines; Phosphatidylinositols; Reference Values | 2002 |
Pregnancy following renal transplantation in class T diabetes mellitus.
Topics: Adult; Amniotic Fluid; Cesarean Section; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fetal Death; Humans; Hypertension; Kidney Transplantation; Phosphatidylcholines; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy in Diabetics; Prenatal Care; Retrospective Studies; Sphingomyelins | 1986 |
Serum phospholipids in diabetic patients with late manifestations.
Topics: Adult; Diabetes Mellitus; Diabetic Angiopathies; Female; Humans; Hyperlipidemias; Male; Middle Aged; Phosphatidylcholines; Phosphatidylethanolamines | 1971 |